Go to deals
Private Equity | Healthcare

Anbioton has been acquired by Elfa Medicamentos

The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.

Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.

Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.

One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.

Service
M&A sell-side
Parties

Talk to the deal team

 Irajá  Guimarães

Irajá Guimarães

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Victor  Andreoli

Victor Andreoli

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Thomas  Monteiro

Thomas Monteiro

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Related deals

SHS has sold Spiegelberg to Luciole Medical AG
Private Equity | Healthcare

SHS has sold Spiegelberg to Luciole Medical AG

SHS and a minority co-shareholder have sold Spiegelberg GmbH to Luciole Medical AG.

Learn more
Zephyr Group has acquired PK OEM Parts
Private Equity | Industrial Machinery & Components | Logistics

Zephyr Group has acquired PK OEM Parts

Zephyr Group has acquired PK OEM Parts. With the entry of PK OEM Parts, Zephyr Group aims to achieve a consolidated turnover of approximately US$65 million in 2023. The acquisition will allow an increase in the services and product range offered to customers by leveraging the group’s know-how and logistical capabilities. Furthermore, the acquisition represents a step forward in the growth and consolidation strategy that Zephyr Group started in 2018 with the acquisition of Spanish competitor SKV.

Learn more
Baird Capital invests in Freemarket
Private Equity | Financial Services

Baird Capital invests in Freemarket

Baird Capital has completed a growth capital investment in Freemarket. The investment supports Freemarket’s continuing fast growth and international expansion, as well as providing a partial cash-out to existing shareholders.

Learn more